BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2011 related articles for article (PubMed ID: 19487306)

  • 1. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells.
    Crome SQ; Wang AY; Kang CY; Levings MK
    Eur J Immunol; 2009 Jun; 39(6):1480-93. PubMed ID: 19449310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
    Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
    Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation.
    Sugimoto A; Suzuki M; Otani T; Okochi A; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2009 Dec; 37(12):1454-63. PubMed ID: 19819295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
    Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR
    Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
    Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
    Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.
    Schneider R; Yaneva T; Beauseigle D; El-Khoury L; Arbour N
    Eur J Immunol; 2011 Jan; 41(1):47-59. PubMed ID: 21182076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Th17/Treg imbalance in patients with acute coronary syndrome.
    Cheng X; Yu X; Ding YJ; Fu QQ; Xie JJ; Tang TT; Yao R; Chen Y; Liao YH
    Clin Immunol; 2008 Apr; 127(1):89-97. PubMed ID: 18294918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis.
    Morita Y; Yamamura M; Kawashima M; Harada S; Tsuji K; Shibuya K; Maruyama K; Makino H
    Arthritis Rheum; 1998 Sep; 41(9):1669-76. PubMed ID: 9751101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
    Sonderegger I; Kisielow J; Meier R; King C; Kopf M
    Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis and role of T cells in psoriasis.
    Ghoreschi K; Weigert C; Röcken M
    Clin Dermatol; 2007; 25(6):574-80. PubMed ID: 18021895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the development and effector functions of TH17 cells.
    Ghilardi N; Ouyang W
    Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
    Lundqvist C; Melgar S; Yeung MM; Hammarström S; Hammarström ML
    J Immunol; 1996 Sep; 157(5):1926-34. PubMed ID: 8757311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.